Investigational ALS drug prolongs patient survival in clinical trial
An experimental medication that was recently shown to slow the progression of amyotrophic lateral sclerosis has now demonstrated the potential to also prolong patient survival. The findings come from a recent clinical trial.
from Latest Science News -- ScienceDaily https://ift.tt/3dzvk49
from Latest Science News -- ScienceDaily https://ift.tt/3dzvk49
Related Posts :
SpaceX Kicks Off a Busy Year With Launch of 60 More Starlink Satellites Into Space- US Consumers Might Get Their First Taste of Transgenic Salmon This Year
- What Fossils Will Modern-Day Civilization Leave Behind?
- Facebook's First CES Reveal In Years Is a Privacy Tool That Falls Short
- Airbnb Claims Its AI Can Predict Whether Guests Are Psychopaths
0 Response to "Investigational ALS drug prolongs patient survival in clinical trial"
Post a Comment